CURA Communications

CURA Communications, a communications firm built for the psychedelics industry, officially launched in January 2023. The company was founded with the mission to manage the complex communications challenges faced by the psychedelics industry with a team of experts who have deep sectoral knowledge, a dedication to the enterprise of bringing novel, safe, and effective treatments to patients, and a commitment to ethical imperatives that should guide the conduct of all those playing a role in the psychedelic renaissance.

The company was founded by Chris Koddermann, who brings several years of experience as a communications and PR consultant and as a co-founder of the International Therapeutic Psilocybin Rescheduling Initiative (Reschedule Psilocybin). He recognized the need for a communications firm that can offer clients industry-specific expertise from a team with direct sectoral experience.

Headquartered in Switzerland, CURA Communications has a presence in London, New York, Toronto and Boulder. The company has assembled an exceptional, multidisciplinary team with first-hand, multi-market experience in the psychedelics and healthcare sector communications and public relations.

CURA Communications offers a range of services including, but not limited to, strategic planning, brand and reputation management, media relations, digital and social media, media training, investor and financial communications, and event management. The company aims to be a valuable partner to its clients by providing industry-specific solutions tailored to their needs, rather than simply selling off-the-shelf services.

The company’s goal is to help its clients navigate the complex communication challenges of the psychedelics industry and to support the ongoing efforts of bringing psychedelic medicines to patients in need.